CYH shares fell 7% to $3.38 following the announcement. CYH agreed to sell Lake Norman Regional Medical Center for $280 million. The sale is part of CYH's strategy for potential divestitures. Closing expected in Q1 2025, pending regulatory approvals. This aligns with CYH's plan discussed during Q3 earnings call.
- CYH reported a quarterly loss of $0.14 per share, beating estimates. - Revenue for the quarter ended March 2024 was $3.14 billion, also beating estimates. - The company's stock has underperformed the market, with shares down 5.4%. - Earnings outlook for CYH is unfavorable, leading to a Zacks Rank #5 (Strong Sell). - Industry outlook can also impact CYH stock performance. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings